Actor portrayal.
Dedicated Support
LEQVIO® provides resources throughout the treatment journey
A dedicated Novartis Patient Support specialist handles all your LEQVIO inquiries and requests for a seamless experience.
- Specialists provide support with insurance coverage, billing and coding information, and patient affordability options
- Our team is equipped to assist every member of your office staff in getting patients started on LEQVIO
- Novartis Patient Support has provided comprehensive support to more than 100,000 patients
Call 1-833-LEQVIO2 (1-833-537-8462) M-F 8:00 AM to 8:00 PM (ET) to get started with the LEQVIO® Service Center.
Dedicated Access Specialist
Available Monday to Friday 8 AM to 8 PM to handle all your service center inquiries and requests for LEQVIO.
To connect with your Dedicated Access Specialist, enter your ZIP code below.
Novartis access & reimbursement expert
- Offers resources and educational information on acquisition and billing & coding
- Available for in-office visits or by phone
- Ask your LEQVIO sales specialist or your dedicated LEQVIO Service Center specialist for their contact information
Sales specialist
Get in touch with a sales specialist for support with product details, acquisition options, and co-pay assistance. Sales specialists do not have access to patient-level data.
"Once I started LEQVIO, managing my cholesterol seemed possible."
– Stacy J., LEQVIO patient compensated for her time.
Individual results may vary.
Billing & Coding
LEQVIO billing & coding information
Find the codes you need to file a claim
| Healthcare Common Procedure Coding System Level II Code1,2 | J1306 - Injection, inclisiran, 1 mg;
JZ modifier: Effective July 1, 2023, providers and suppliers are required to report the JZ modifier on all claims that bill for drugs from single-dose containers that are separately payable under Medicare Part B when there are no discarded amounts. TB modifier: Starting January 1, 2025, the updated CMS guidance requires 340B covered entities to only report the TB modifier on claims for products acquired through the 340B program. Do not use the JG modifier for claims with dates of service after December 31, 2024. This update will impact Medicare providers and suppliers who bill for separately payable Part B drugs and biologics and participate in the 340B Pricing Program. |
| Current Procedural Terminology Code3* | 96372 - Therapeutic, Prophylactic, and Diagnostic Injection (specific substance or drug; subcutaneous or intramuscular) |
| International Classification of Diseases, 10th Revision, Clinical Modification | To find a full list of ICD-10 codes that may be relevant for LEQVIO, download our Billing & Coding Guide |
| National Drug Code4 | 10-digit: 0078-1000-60 11-digit: 00078-1000-60 |
| Place of Service (POS) Codes5 | 11 – Office 22 – On campus – Outpatient Hospital |
| Revenue Codes5 (hospital outpatient department administration only) | 0636 - Drugs requiring detailed coding 0250 - General pharmacy 0500 - General outpatient services 0510 - General clinic services |
*CPT © 2024 American Medical Association. All rights reserved.
To find a full list of codes that may be related to LEQVIO, download our Billing & Coding Guide.
Annotated CMS Claim Forms
To see example claim forms for LEQVIO, download our Annotated Claim Forms.
Download CMS-1500 Claim Form
Download CMS-1450 (UB-04) Claim Form
LEQVIO Claims and Coding Considerations
The information herein is provided for educational purposes only. Novartis cannot guarantee insurance coverage or reimbursement. Coverage and reimbursement may vary significantly by payer, plan, patient, and setting of care. It is the sole responsibility of the health care professional to select the proper codes and ensure the accuracy of all statements used in seeking coverage and reimbursement for an individual patient.
Forms & Guides Library
Resources and forms for every step of the way
Enrollment
Patient Coverage
Financial Support
There's more to know about LEQVIO
Discover supportive resources available to help your patients get started on LEQVIO to help reduce LDL-C
.